IGF1 and breast carcinoma: The distributions of circulating IGFs, bioactive IGF, IGFBP‐3, and PAPP‐A, according to tertiles of IGFBP‐2 and PAPP‐A, for women with breast cancer versus controls (516 with complete IGF data), are shown in Table 2.